The global demand for Vero Cell Rabies Vaccine Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
Inactivated rabies vaccine cultivated on Vero cells is known as Vero cell rabies vaccine (PVRV). The Vero cell rabies vaccine is both immunogenic and safe for pre-exposure prevention and post-exposure treatment. The central nervous systems of dogs are the most commonly affected animals by rabies. A bite, skin laceration, or scratch from an infected animal can spread the zoonotic disease rabies to people or other dogs. The risk of rabies transmission from an infected dog to a human being is decreased due to the Vero cell rabies vaccine.
Market Dynamics
The vero cell rabies vaccine market is witnessing substantial growth due to the increased government measures toward preventing the disease. The increasing pet adoption and the rising number of zoonotic diseases are other factors driving the market growth. In addition, the surge in rabies infection in humans due to domestication of dogs or other animals and increasing awareness regarding disease among people are factors further fueling the market growth. Furthermore, increasing research and development activities and a rise in veterinary healthcare spending are also propelling the market growth for the vero cell rabies vaccine.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of vero cell rabies vaccine. The growth and trends of vero cell rabies vaccine industry provide a holistic approach to this study.
Market Segmentation
This section of the vero cell rabies vaccine market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Application
- Post-Exposure Prophylaxis
- Pre-Exposure Prophylaxis
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Vero Cell Rabies Vaccine market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Vero Cell Rabies Vaccine Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the vero cell rabies vaccine market include Sanofi Pasteur, Inc., ChengDa PharmaCeuticals Co., Ltd, Berkeley Center for Health Technology, Changsheng Bio-Technology, GSK (Novartis), Chengda, Yisheng, Prcmise, VACN and Changsheng. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.